Mention a common side effect associated with taxanes in chemotherapy.

Mention a common side effect associated with taxanes in chemotherapy.

• A. Hair loss
• B. Peripheral neuropathy
• C. Nausea and vomiting
• D. Hyperglycemia

Answer: (B)

Peripheral neuropathy is a well-documented side effect associated with the use of taxanes in chemotherapy. Taxanes, such as paclitaxel and docetaxel, are known for their mechanism of action that disrupts microtubule function, which can lead to damage to peripheral nerves. This neurological impairment may manifest as symptoms like tingling, numbness, or pain in the extremities. While hair loss, nausea and vomiting, and hyperglycemia can occur with various chemotherapeutic agents, they are not primarily associated with taxanes. Hair loss is a common side effect of several chemotherapy drugs due to their effects on rapidly dividing cells, but it is not specific to taxanes. Nausea and vomiting can occur with many chemotherapeutics and are managed with antiemetics, but taxanes are not the primary contributors. Hyperglycemia is not typically linked with taxane treatment and is more relevant to other classes of medications, such as corticosteroids. Thus, the association of peripheral neuropathy with taxanes underscores an important aspect of their clinical management and monitoring during chemotherapy.

Peripheral neuropathy is a well-documented side effect associated with the use of taxanes in chemotherapy. Taxanes, such as paclitaxel and docetaxel, are known for their mechanism of action that disrupts microtubule function, which can lead to damage to peripheral nerves. This neurological impairment may manifest as symptoms like tingling, numbness, or pain in the extremities.

While hair loss, nausea and vomiting, and hyperglycemia can occur with various chemotherapeutic agents, they are not primarily associated with taxanes. Hair loss is a common side effect of several chemotherapy drugs due to their effects on rapidly dividing cells, but it is not specific to taxanes. Nausea and vomiting can occur with many chemotherapeutics and are managed with antiemetics, but taxanes are not the primary contributors. Hyperglycemia is not typically linked with taxane treatment and is more relevant to other classes of medications, such as corticosteroids. Thus, the association of peripheral neuropathy with taxanes underscores an important aspect of their clinical management and monitoring during chemotherapy.